Changyu Ren

618 total citations
19 papers, 417 citations indexed

About

Changyu Ren is a scholar working on Molecular Biology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Changyu Ren has authored 19 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Changyu Ren's work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Changyu Ren is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Changyu Ren collaborates with scholars based in China, United States and Luxembourg. Changyu Ren's co-authors include Jifa Zhang, Yuxi Wang, Jiaxing Wang, Liang Ouyang, Tong Liu, Hao Chen, Souvik Banerjee, Jia Zeng, Ying Sun and Wuyu Mao and has published in prestigious journals such as Journal of Medicinal Chemistry, Frontiers in Immunology and Life Sciences.

In The Last Decade

Changyu Ren

18 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changyu Ren China 11 261 64 38 37 37 19 417
Ulf Soppa Germany 8 394 1.5× 68 1.1× 64 1.7× 16 0.4× 30 0.8× 9 626
Yoonsuk Cho South Korea 10 279 1.1× 23 0.4× 26 0.7× 25 0.7× 54 1.5× 16 427
Jaya Gautam South Korea 13 247 0.9× 93 1.5× 59 1.6× 22 0.6× 85 2.3× 19 472
Yves Leestemaker Netherlands 6 348 1.3× 65 1.0× 13 0.3× 15 0.4× 24 0.6× 7 498
Anna A. Rybczynska Netherlands 12 402 1.5× 93 1.5× 74 1.9× 22 0.6× 66 1.8× 20 566
Sofia Zanin Italy 13 437 1.7× 51 0.8× 24 0.6× 10 0.3× 37 1.0× 21 547
Philipp Lampe Germany 10 553 2.1× 28 0.4× 29 0.8× 11 0.3× 30 0.8× 18 651
Femke M. Feringa Netherlands 8 320 1.2× 96 1.5× 15 0.4× 11 0.3× 21 0.6× 14 508
Chaeyoung Kim South Korea 10 313 1.2× 20 0.3× 66 1.7× 15 0.4× 61 1.6× 15 446
Karolina Dzwonek Poland 11 160 0.6× 69 1.1× 38 1.0× 6 0.2× 61 1.6× 23 355

Countries citing papers authored by Changyu Ren

Since Specialization
Citations

This map shows the geographic impact of Changyu Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyu Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyu Ren more than expected).

Fields of papers citing papers by Changyu Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changyu Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyu Ren. The network helps show where Changyu Ren may publish in the future.

Co-authorship network of co-authors of Changyu Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Changyu Ren. A scholar is included among the top collaborators of Changyu Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changyu Ren. Changyu Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ren, Changyu, et al.. (2025). Dual inhibition of BRAF for cancer treatment: advances and therapeutic potential. Future Medicinal Chemistry. 17(22). 2735–2750.
2.
Zhang, Linxi, et al.. (2024). Development and therapeutic implications of small molecular inhibitors that target calcium-related channels in tumor treatment. Drug Discovery Today. 29(6). 103995–103995. 4 indexed citations
3.
He, Ketai, Mingkun Chen, Jiao Liu, et al.. (2024). Nanomedicine for cancer targeted therapy with autophagy regulation. Frontiers in Immunology. 14. 1238827–1238827. 3 indexed citations
4.
Chen, Li, Wuyu Mao, Changyu Ren, Jinqi Li, & Jifa Zhang. (2024). Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles. Journal of Medicinal Chemistry. 67(1). 38–64. 18 indexed citations
5.
Ren, Changyu, et al.. (2024). Medicinal chemistry aspects of fat mass and obesity associated protein: structure, function and inhibitors. Future Medicinal Chemistry. 16(16). 1705–1726. 3 indexed citations
6.
7.
Wang, Yuxi, et al.. (2023). Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects. European Journal of Medicinal Chemistry. 261. 115800–115800. 10 indexed citations
8.
Hu, Jiarui, Dan Zhang, Changyu Ren, et al.. (2023). Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives. European Journal of Medicinal Chemistry. 256. 115475–115475. 29 indexed citations
9.
Wang, Liran, et al.. (2023). Delving into Commit-Issue Correlation to Enhance Commit Message Generation Models. Open Repository and Bibliography (University of Luxembourg). 710–722. 5 indexed citations
10.
Ren, Changyu, et al.. (2023). PDE4 Inhibitors for Disease Therapy: Advances and Future Perspective. Future Medicinal Chemistry. 15(13). 1185–1207. 9 indexed citations
11.
Wang, Jiaxing, et al.. (2022). Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy. Journal of Medicinal Chemistry. 65(17). 11454–11477. 52 indexed citations
12.
Zhang, Jifa, et al.. (2022). Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective. European Journal of Medicinal Chemistry. 240. 114595–114595. 10 indexed citations
13.
Zhang, Jifa, et al.. (2022). Current progress and novel strategies that target CDK12 for drug discovery. European Journal of Medicinal Chemistry. 240. 114603–114603. 11 indexed citations
14.
Zhang, Ya, Zelin Hu, Jifa Zhang, Changyu Ren, & Yuxi Wang. (2022). Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy. European Journal of Medicinal Chemistry. 238. 114524–114524. 28 indexed citations
15.
Zeng, Jia, Jifa Zhang, Ying Sun, et al.. (2022). Targeting EZH2 for cancer therapy: From current progress to novel strategies. European Journal of Medicinal Chemistry. 238. 114419–114419. 74 indexed citations
16.
Zhang, Lele, Jifa Zhang, Jiaxing Wang, et al.. (2022). Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives. European Journal of Medicinal Chemistry. 232. 114176–114176. 31 indexed citations
17.
Dong, Yunzhou, Changyu Ren, Dan Zhang, et al.. (2022). Targeting FGFRs for Tumor Therapy: Current Status and Novel Strategies. Future Medicinal Chemistry. 14(24). 1923–1941. 1 indexed citations
18.
Liu, Tong, Yuxi Wang, Jiaxing Wang, et al.. (2021). DYRK1A inhibitors for disease therapy: Current status and perspectives. European Journal of Medicinal Chemistry. 229. 114062–114062. 79 indexed citations
19.
Guo, Yuanxin, Xiaohong Tracey Gan, Hongjing Zhou, et al.. (2020). Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation. Life Sciences. 263. 118582–118582. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Soppa Breakdown of academic impact, for papers by Yoonsuk Cho Breakdown of academic impact, for papers by Jaya Gautam Breakdown of academic impact, for papers by Yves Leestemaker Breakdown of academic impact, for papers by Anna A. Rybczynska Breakdown of academic impact, for papers by Sofia Zanin Breakdown of academic impact, for papers by Philipp Lampe Breakdown of academic impact, for papers by Femke M. Feringa Breakdown of academic impact, for papers by Chaeyoung Kim Breakdown of academic impact, for papers by Karolina Dzwonek
Rankless by CCL
2026